Funding
Series D · Healthtech

Cagent Vascular raises $41M Series D

Cagent Vascular raised $41 million in Series D financing announced in May.

Updated Oct 16, 2026By RoundOS Funding desk

U.S. Venture Partners and Astoria Health Investors are among its backers.

The company develops endovascular serration and lithotripsy technologies for peripheral and coronary artery disease.

Funding history

Series D · This round$41M

Sources

  1. Cagent Vascularprojectstartups.com
  2. businesswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Yizhu Technology

Yizhu Technology designs compute-in-memory chips for AI inference and post-training workloads.

>CN¥1BUndisclosed · Oct 23, 2026
Fairy Devices

Tokyo company developing wearable devices and remote-assistance software for industrial field workers.

UndisclosedJICN equity investment · Oct 23, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related